Advaxis Receives Preliminary Approval for Sale of Losses from State of NJ Economic Development Authority

Advaxis Receives Preliminary Approval for Sale of Losses from State of NJ Economic Development Authority

[at noodls] – Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has received preliminary approval for $796,913 from the … more

View todays social media effects on ADXS

View the latest stocks trending across Twitter. Click to view dashboard

See who Advaxis is hiring next, click here to view

Share this post